Mark J. Mulvihill

2.1k total citations
49 papers, 1.5k citations indexed

About

Mark J. Mulvihill is a scholar working on Molecular Biology, Organic Chemistry and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Mark J. Mulvihill has authored 49 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 19 papers in Organic Chemistry and 13 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Mark J. Mulvihill's work include Growth Hormone and Insulin-like Growth Factors (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Mark J. Mulvihill is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (13 papers), Metabolism, Diabetes, and Cancer (9 papers) and PI3K/AKT/mTOR signaling in cancer (7 papers). Mark J. Mulvihill collaborates with scholars based in United States, Canada and United Kingdom. Mark J. Mulvihill's co-authors include Marvin J. Miller, Elizabeth Buck, Qunsheng Ji, M. D. Surman, Maryland Rosenfeld-Franklin, Neil W. Gibson, Andrew Cooke, Matthew O’Connor, Caroline Pirritt and Lee D. Arnold and has published in prestigious journals such as The EMBO Journal, Biochemistry and Cancer Research.

In The Last Decade

Mark J. Mulvihill

46 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J. Mulvihill United States 21 863 536 363 252 214 49 1.5k
Lee D. Arnold United States 18 1.1k 1.3× 493 0.9× 182 0.5× 540 2.1× 168 0.8× 37 1.9k
Kevin Kish United States 20 930 1.1× 381 0.7× 384 1.1× 265 1.1× 61 0.3× 38 2.0k
Elaine S. E. Stokes United Kingdom 17 999 1.2× 367 0.7× 141 0.4× 609 2.4× 276 1.3× 28 1.7k
Darren McKerrecher United Kingdom 16 508 0.6× 466 0.9× 160 0.4× 168 0.7× 75 0.4× 28 1.2k
Richard M. Keenan United States 23 576 0.7× 394 0.7× 177 0.5× 175 0.7× 48 0.2× 39 1.4k
Akihiko Tsuruoka Japan 14 661 0.8× 286 0.5× 330 0.9× 514 2.0× 274 1.3× 30 1.7k
Naoko Hata Sugi Japan 10 905 1.0× 321 0.6× 92 0.3× 362 1.4× 127 0.6× 14 1.3k
Phyllis M. Goddard United Kingdom 20 518 0.6× 486 0.9× 101 0.3× 695 2.8× 118 0.6× 30 1.4k
Hans‐Georg Capraro Switzerland 12 507 0.6× 181 0.3× 230 0.6× 214 0.8× 139 0.6× 24 926
Jeremy Murray United States 22 1.4k 1.6× 204 0.4× 68 0.2× 311 1.2× 99 0.5× 36 1.8k

Countries citing papers authored by Mark J. Mulvihill

Since Specialization
Citations

This map shows the geographic impact of Mark J. Mulvihill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J. Mulvihill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J. Mulvihill more than expected).

Fields of papers citing papers by Mark J. Mulvihill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J. Mulvihill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J. Mulvihill. The network helps show where Mark J. Mulvihill may publish in the future.

Co-authorship network of co-authors of Mark J. Mulvihill

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J. Mulvihill. A scholar is included among the top collaborators of Mark J. Mulvihill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J. Mulvihill. Mark J. Mulvihill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tameire, Feven, Crissy Dudgeon, Kathryn Bieging-Rolett, et al.. (2025). In Vivo Tumor Growth Control by General Control Nonderepressible 2–Targeting Agents Results from Kinase Activation. Molecular Cancer Therapeutics. 25(1). 71–83.
2.
Stokes, Michael E., Verónica Calvo, Sho Fujisawa, et al.. (2023). PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors. Clinical Cancer Research. 29(23). 4870–4882. 16 indexed citations
3.
Calvo, Verónica, Wei Zheng, Anna Adam‐Artigues, et al.. (2023). A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response–Dependent Survival of Quiescent Cancer Cells. Clinical Cancer Research. 29(24). 5155–5172. 23 indexed citations
4.
Stokes, Michael E., M. D. Surman, Verónica Calvo, et al.. (2022). Optimization of a Novel Mandelamide-Derived Pyrrolopyrimidine Series of PERK Inhibitors. Pharmaceutics. 14(10). 2233–2233. 5 indexed citations
5.
6.
Marcaurelle, Lisa A. & Mark J. Mulvihill. (2016). Nuphar Dimers: Crouching Sulfur, Hidden Reactivity. ACS Central Science. 2(6). 367–369. 4 indexed citations
7.
Lin, Yi‐Chun, et al.. (2014). The RON Receptor Tyrosine Kinase Promotes Metastasis by Triggering MBD4-Dependent DNA Methylation Reprogramming. Cell Reports. 6(1). 141–154. 39 indexed citations
8.
Jin, Meizhong, Jing Wang, Elizabeth Buck, & Mark J. Mulvihill. (2012). Small-Molecule ATP-Competitive Dual IGF-1R And Insulin Receptor Inhibitors: Structural Insights, Chemical Diversity And Molecular Evolution. Future Medicinal Chemistry. 4(3). 315–328. 13 indexed citations
9.
Buck, Elizabeth & Mark J. Mulvihill. (2011). Small molecule inhibitors of the IGF-1R/IR axis for the treatment of cancer. Expert Opinion on Investigational Drugs. 20(5). 605–621. 51 indexed citations
10.
Buck, Elizabeth, Mark J. Mulvihill, & Kenneth K. Iwata. (2010). Pursuit of Personalized Anticancer Therapy: Leveraging Collaboration Between Academia and the Biotech/Pharmaceutical Industry. Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine. 77(4). 358–365. 2 indexed citations
11.
Wang, Jianxin, Andrew P. Crew, Meizhong Jin, et al.. (2009). Synthesis of Substituted Imidazo[1,5-a]pyrazines via Mono-, Di-, and Directed Remote Metalation Strategies. Organic Letters. 11(22). 5118–5121. 1 indexed citations
12.
Buck, Elizabeth, Alexandra Eyzaguirre, Maryland Rosenfeld-Franklin, et al.. (2008). Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors. Cancer Research. 68(20). 8322–8332. 164 indexed citations
13.
14.
Rosenfeld-Franklin, Maryland, Caroline Pirritt, Darla Landfair, et al.. (2007). In vivo evaluation of OSI-906, a novel small molecule kinase inhibitor of the insulin-like growth factor-1 receptor (IGF-1R). Molecular Cancer Therapeutics. 6. 5 indexed citations
15.
Ji, Qunsheng, Mark J. Mulvihill, Maryland Rosenfeld-Franklin, et al.. (2007). Preclinical characterization of OSI-906: A novel IGF-1R kinase inhibitor in clinical trials. Molecular Cancer Therapeutics. 6. 4 indexed citations
16.
Mulvihill, Mark J., Qunsheng Ji, Heather Coate, et al.. (2007). Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors. Bioorganic & Medicinal Chemistry. 16(3). 1359–1375. 59 indexed citations
17.
Li, An‐Hu, Xin Chen, Matthew Cox, et al.. (2006). A highly effective one-pot synthesis of quinolines from o-nitroarylcarbaldehydes. Organic & Biomolecular Chemistry. 5(1). 61–64. 72 indexed citations
18.
Surman, M. D., Mark J. Mulvihill, & Marvin J. Miller. (2002). Regio- and Stereoselective Ring Openings of 3-Aza-2-oxabicyclo[2.2.1]hept-5-ene Systems with Copper Catalyst-Modified Grignard Reagents:  Application to the Synthesis of an Inhibitor of 5-Lipoxygenase. The Journal of Organic Chemistry. 67(12). 4115–4121. 47 indexed citations
19.
Mulvihill, Mark J., et al.. (2001). A Novel Convenient Synthesis of 1,3,4-Oxadiazol-2-ones and -thiones from N-tert-Butyldiacylhydrazines. Synthesis. 2001(13). 1965–1970. 13 indexed citations
20.
Mulvihill, Mark J., et al.. (1998). Enzymatic Resolution of Aminocyclopentenols as Precursors to d- and l-Carbocyclic Nucleosides. The Journal of Organic Chemistry. 63(10). 3357–3363. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lee D. Arnold Breakdown of academic impact, for papers by Kevin Kish Breakdown of academic impact, for papers by Elaine S. E. Stokes Breakdown of academic impact, for papers by Darren McKerrecher Breakdown of academic impact, for papers by Richard M. Keenan Breakdown of academic impact, for papers by Akihiko Tsuruoka Breakdown of academic impact, for papers by Naoko Hata Sugi Breakdown of academic impact, for papers by Phyllis M. Goddard Breakdown of academic impact, for papers by Hans‐Georg Capraro Breakdown of academic impact, for papers by Jeremy Murray
Rankless by CCL
2026